Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Orchestra BioMed Holdings, Inc. - Ordinary Shares (NQ: OBIO ) 6.740 -0.110 (-1.61%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 89,057 Open 6.710 Bid (Size) 6.520 (5) Ask (Size) 10.89 (2) Prev. Close 6.850 Today's Range 6.570 - 7.240 52wk Range 4.220 - 11.69 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors July 30, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances July 23, 2024 Jayme Strauss and Mike Kaswan join as Chief Clinical and Commercial Officer and Chief Financial Officer, respectively, as the company progresses toward FDA clearance From Precision Neuroscience Via GlobeNewswire Performance YTD -23.23% -23.23% 1 Month -10.96% -10.96% 3 Month +32.16% +32.16% 6 Month -5.20% -5.20% 1 Year +20.57% +20.57% More News Read More Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 June 04, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed to Participate in Jefferies Global Healthcare Conference May 22, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024 May 13, 2024 Via InvestorPlace Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update May 13, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session May 02, 2024 Via Benzinga Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents April 30, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 April 30, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q4 2023 March 27, 2024 Via InvestorPlace Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update March 27, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors March 26, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting March 13, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed to Participate in Upcoming Investor Conferences March 07, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients March 06, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years February 26, 2024 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update November 13, 2023 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire Top 4 Health Care Stocks That Should Keep You Up At Night September 21, 2023 Via Benzinga Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session September 20, 2023 Via Benzinga Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 19, 2023 Via Benzinga Why Shares of Orchestra BioMed Jumped Tuesday September 19, 2023 Via The Motley Fool Exposures Product Safety Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet September 19, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday September 19, 2023 Via Benzinga Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients September 19, 2023 From Orchestra BioMed Holdings, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session September 15, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
